FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 227 filers reported holding FATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,147,798 | -56.3% | 212,864 | -2.9% | 0.12% | -56.8% |
| Q3 2022 | $4,911,000 | -27.4% | 219,146 | -19.7% | 0.28% | -12.8% |
| Q2 2022 | $6,766,000 | -29.0% | 273,033 | +11.0% | 0.33% | -13.9% |
| Q1 2022 | $9,534,000 | -34.9% | 245,916 | -1.7% | 0.38% | -26.9% |
| Q4 2021 | $14,640,000 | -5.3% | 250,212 | -4.0% | 0.52% | -8.9% |
| Q3 2021 | $15,455,000 | -46.9% | 260,756 | -22.3% | 0.57% | -44.8% |
| Q2 2021 | $29,112,000 | -8.1% | 335,427 | -12.7% | 1.04% | +0.2% |
| Q1 2021 | $31,691,000 | -10.0% | 384,362 | -0.8% | 1.03% | -16.6% |
| Q4 2020 | $35,220,000 | +169.6% | 387,327 | +18.5% | 1.24% | +135.6% |
| Q3 2020 | $13,064,000 | – | 326,844 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |